|
2024
|
Invention
|
Methods of producing long-acting coagulation factors.
Polypeptides comprising at least one carbo... |
|
2022
|
Invention
|
Methods of administering long-acting growth hormone polypeptides.
The subject matter described h... |
|
|
Invention
|
Methods of administering long-acting growth hormone polypeptides. The subject matter described he... |
|
|
Invention
|
Long-acting growth hormone compositions. The subject matter described herein is directed to pharm... |
|
2021
|
Invention
|
Long-acting polypeptides and methods of producing and administering same. CTP-modified human grow... |
|
|
Invention
|
Long-acting coagulation factors and methods of producing same. Polypeptides comprising at least o... |
|
|
Invention
|
Long-acting coagulation factors and methods of producing same.
Polypeptides comprising at least ... |
|
|
Invention
|
Methods of producing long acting ctp-modified polypeptides.
Disclosed herein is a method for man... |
|
2020
|
Invention
|
Long-acting igf-1 or igf-1 variants and methods of producing same.
Compositions which include po... |
|
|
Invention
|
Long-acting igf-1 or igf-1 variants and methods of producing same. Compositions which include pol... |
|
|
Invention
|
Long-acting glp-2 analogs. Compositions which include glucagon-like peptide-2 (GLP-2) analogs, GL... |
|
|
Invention
|
Long-acting glp-2 analogs.
Compositions which include glucagon-like peptide-2 (GLP-2) analogs, G... |
|
2019
|
Invention
|
Methods of treatment with long-acting hormone.
Use of a growth hormone protein and polynucleotid... |
|
|
Invention
|
Long-acting human growth hormone-antagonists and methods of producing the same. Compositions whic... |
|
2018
|
Invention
|
Long-acting polypeptides and methods of producing same.
A polypeptide and polynucleotides encodi... |
|
2017
|
Invention
|
Pegylated oxm variants.
A composition which includes oxyntomodulin and polyethylene glycol polym... |
|
|
Invention
|
Long-acting coagulation factor vii and methods of producing same. Polypeptides comprising at leas... |
|
|
Invention
|
Long-acting oxyntomodulin formulation and methods of producing and administering same.
Pharmaceu... |
|
|
Invention
|
Long-acting oxyntomodulin formulation and methods of producing and administering same. Pharmaceut... |
|
2016
|
Invention
|
Long-acting oxyntomodulin variants and methods of producing same.
This invention is directed to ... |
|
|
Invention
|
Long-acting coagulation factors and methods of producing same. Polypeptides comprising at l... |
|
|
Invention
|
Pegylated oxyntomodulin variants. A composition which includes oxyntomodulin and polyethylene gly... |
|
2015
|
Invention
|
Methods of producing long acting ctp-modified growth hormone polypeptides.
Disclosed herein is a... |
|
|
Invention
|
Methods of producing long acting ctp-modified growth hormone polypeptides. Disclosed herein is a ... |
|
|
Invention
|
Methods of producing long acting ctp-modified polypeptides. Disclosed herein is a method for manu... |
|
|
Invention
|
Methods of producing ctp-modified growth hormone polypeptides. Disclosed herein is a metho... |
|
|
Invention
|
Pegylated oxm variants. A composition which includes oxyntomodulin and polyethylene glycol polyme... |
|
2014
|
Invention
|
Long-acting polypeptides and methods of producing same. A polypeptide and polynucleotides encodin... |
|
|
Invention
|
Long-acting polypeptides and methods of producing and administering same. A polypeptide and polyn... |
|
|
Invention
|
Long-acting polypeptides and methods of producing and administering same.
CTP-modified human gro... |
